Previous Article | Next Article 
Journal of Virology, February 2000, p. 1554-1557, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production
In Vivo
Stephen J.
Popper,1
Abdoulaye Dieng
Sarr,1
Aïssatou
Guèye-Ndiaye,2
Souleymane
Mboup,2
Myron E.
Essex,1 and
Phyllis J.
Kanki1,*
Department of Immunology and Infectious
Diseases and the Harvard AIDS Institute, Harvard School of Public
Health, Boston, Massachusetts,1 and
Laboratoire de Bactériologie-Virologie, Université
Cheikh Anta Diop, Dakar, Senegal2
Received 27 July 1999/Accepted 21 October 1999
Levels of virus in the plasma are closely related to the
pathogenicity of human immunodeficiency virus type 1 (HIV-1). HIV-2 is
much less pathogenic than HIV-1, and infection with HIV-2 leads to
significantly lower plasma viral load. To identify the source of this
difference, we measured both viral RNA and proviral DNA in matched
samples from 34 HIV-2-infected individuals. Nearly half had
undetectable viral RNA loads (<100 copies/ml), but levels of proviral
DNA were relatively high and confirmed that quantities of provirus in
HIV-1 and HIV-2 infection were similar. Overall, HIV-2 proviral DNA
load did not correlate with viral RNA load, and higher viral RNA load
was associated with increased production of plasma virus from the
proviral template. These results suggest that low viral load in HIV-2
infection is due to decreased rates of viral production, rather than
differences in target cell infectivity.
*
Corresponding author. Mailing address: Department of
Immunology and Infectious Diseases, Harvard School of Public Health, 651 Huntington Ave., Boston, MA 02115. Phone: (617) 432-1267. Fax:
(617) 432-3575. E-mail: pkanki{at}hsph.harvard.edu.
Journal of Virology, February 2000, p. 1554-1557, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Feldmann, J., Leligdowicz, A., Jaye, A., Dong, T., Whittle, H., Rowland-Jones, S. L.
(2009). Downregulation of the T-Cell Receptor by Human Immunodeficiency Virus Type 2 Nef Does Not Protect against Disease Progression. J. Virol.
83: 12968-12972
[Abstract]
[Full Text]
-
Foxall, R. B., Cortesao, C. S., Albuquerque, A. S., Soares, R. S., Victorino, R. M. M., Sousa, A. E.
(2008). Gag-Specific CD4+ T-Cell Frequency Is Inversely Correlated with Proviral Load and Directly Correlated with Immune Activation in Infection with Human Immunodeficiency Virus Type 2 (HIV-2) but Not HIV-1. J. Virol.
82: 9795-9799
[Abstract]
[Full Text]
-
Jennes, W., Camara, M., Dieye, T., Mboup, S., Kestens, L.
(2008). Higher Homologous and Lower Cross-Reactive Gag-Specific T-Cell Responses in Human Immunodeficiency Virus Type 2 (HIV-2) Than in HIV-1 Infection. J. Virol.
82: 8619-8628
[Abstract]
[Full Text]
-
Sen, P., Charini, W. A., Subbramanian, R. A., Manuel, E. R., Kuroda, M. J., Autissier, P. A., Letvin, N. L.
(2008). Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge. J. Virol.
82: 805-816
[Abstract]
[Full Text]
-
Gautier, D., Beq, S., Cortesao, C. S., Sousa, A. E., Cheynier, R.
(2007). Efficient Thymopoiesis Contributes to the Maintenance of Peripheral CD4 T Cells during Chronic Human Immunodeficiency Virus Type 2 Infection. J. Virol.
81: 12685-12688
[Abstract]
[Full Text]
-
Rodriguez, S. K., Sarr, A. D., MacNeil, A., Thakore-Meloni, S., Gueye-Ndiaye, A., Traore, I., Dia, M. C., Mboup, S., Kanki, P. J.
(2007). Comparison of Heterologous Neutralizing Antibody Responses of Human Immunodeficiency Virus Type 1 (HIV-1)- and HIV-2-Infected Senegalese Patients: Distinct Patterns of Breadth and Magnitude Distinguish HIV-1 and HIV-2 Infections. J. Virol.
81: 5331-5338
[Abstract]
[Full Text]
-
MacNeil, A., Sarr, A. D., Sankale, J.-L., Meloni, S. T., Mboup, S., Kanki, P.
(2007). Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection. J. Virol.
81: 5325-5330
[Abstract]
[Full Text]
-
Albuquerque, A. S., Cortesao, C. S., Foxall, R. B., Soares, R. S., Victorino, R. M. M., Sousa, A. E.
(2007). Rate of Increase in Circulating IL-7 and Loss of IL-7R{alpha} Expression Differ in HIV-1 and HIV-2 Infections: Two Lymphopenic Diseases with Similar Hyperimmune Activation but Distinct Outcomes. J. Immunol.
178: 3252-3259
[Abstract]
[Full Text]
-
Soares, R., Foxall, R., Albuquerque, A., Cortesao, C., Garcia, M., Victorino, R. M. M., Sousa, A. E.
(2006). Increased Frequency of Circulating CCR5+ CD4+ T Cells in Human Immunodeficiency Virus Type 2 Infection. J. Virol.
80: 12425-12429
[Abstract]
[Full Text]
-
MacNeil, A., Sankale, J.-L., Meloni, S. T., Sarr, A. D., Mboup, S., Kanki, P.
(2006). Genomic Sites of Human Immunodeficiency Virus Type 2 (HIV-2) Integration: Similarities to HIV-1 In Vitro and Possible Differences In Vivo.. J. Virol.
80: 7316-7321
[Abstract]
[Full Text]
-
Marchant, D., Neil, S. J. D., McKnight, A.
(2006). Human immunodeficiency virus types 1 and 2 have different replication kinetics in human primary macrophage culture. J. Gen. Virol.
87: 411-418
[Abstract]
[Full Text]
-
Post, K., Guo, J., Howard, K. J., Powell, M. D., Miller, J. T., Hizi, A., Le Grice, S. F. J., Levin, J. G.
(2003). Human Immunodeficiency Virus Type 2 Reverse Transcriptase Activity in Model Systems That Mimic Steps in Reverse Transcription. J. Virol.
77: 7623-7634
[Abstract]
[Full Text]
-
Lopes, A. R., Jaye, A., Dorrell, L., Sabally, S., Alabi, A., Jones, N. A., Flower, D. R., De Groot, A., Newton, P., Lascar, R. M., Williams, I., Whittle, H., Bertoletti, A., Borrow, P., Maini, M. K.
(2003). Greater CD8+ TCR Heterogeneity and Functional Flexibility in HIV-2 Compared to HIV-1 Infection. J. Immunol.
171: 307-316
[Abstract]
[Full Text]
-
Mani, I., Gilbert, P., Sankale, J.-L., Eisen, G., Mboup, S., Kanki, P. J.
(2002). Intrapatient Diversity and Its Correlation with Viral Setpoint in Human Immunodeficiency Virus Type 1 CRF02_A/G-IbNG Infection. J. Virol.
76: 10745-10755
[Abstract]
[Full Text]
-
Damond, F., Gueudin, M., Pueyo, S., Farfara, I., Robertson, D. L., Descamps, D., Chene, G., Matheron, S., Campa, P., Brun-Vezinet, F., Simon, F.
(2002). Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B Infections. J. Clin. Microbiol.
40: 3654-3659
[Abstract]
[Full Text]
-
Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., Victorino, R. M. M.
(2002). CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load. J. Immunol.
169: 3400-3406
[Abstract]
[Full Text]
-
Reeves, J. D., Doms, R. W.
(2002). Human immunodeficiency virus type 2. J. Gen. Virol.
83: 1253-1265
[Full Text]
-
Damond, F., Descamps, D., Farfara, I., Telles, J. N., Puyeo, S., Campa, P., Lepretre, A., Matheron, S., Brun-Vezinet, F., Simon, F.
(2001). Quantification of Proviral Load of Human Immunodeficiency Virus Type 2 Subtypes A and B Using Real-Time PCR. J. Clin. Microbiol.
39: 4264-4268
[Abstract]
[Full Text]
-
Lawn, S. D., Butera, S. T., Folks, T. M.
(2001). Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin. Microbiol. Rev.
14: 753-777
[Abstract]
[Full Text]
-
Kokkotou, E. G., Sankale, J.-L., Mani, I., Gueye-Ndiaye, A., Schwartz, D., Essex, M. E., Mboup, S., Kanki, P. J.
(2000). In vitro correlates of HIV-2-mediated HIV-1 protection. Proc. Natl. Acad. Sci. USA
97: 6797-6802
[Abstract]
[Full Text]